Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasudil for prevention of PCI-related myocardial injury in stable coronary artery disease
jRCTs021180031Completed
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronary arteriosclerosis comparing Fasudil arm with Placebo arm (2 arms). Primary endpoint: Index of Microvascular Resistance. Started Jan 2018; status: completed.
02
Drugs
fasudil
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on jRCTs021180031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180031.